Please login to the form below

Not currently logged in
Email:
Password:

COVID-19 and coronavirus

Positive results for GSK/CureVac’s COVID-19 vaccine

Positive results for GSK/CureVac’s COVID-19 vaccine

The partnership is focusing on developing a novel mRNA-based COVID-19 vaccine by using multivalent and monovalent approaches to offer broader protection against newly emerging variants. ... mRNA technology has made tremendous progress since the clinical

Latest news

More from news
Approximately 0 fully matching, plus 410 partially matching documents found.

Latest Intelligence

  • The pandemic preparedness paradox The pandemic preparedness paradox

    We must act now. It would be easier to start this work after COVID-19, after we all have our feet under us once again. ... control of COVID-19, the next emergency will draw all attention and sap the collective will.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    a 10-day dosing regimen of remdesivir administered intravenously versus standard of care in patients with moderate manifestations of COVID-19. ... The European Commission has signed a joint procurement agreement for Gilead’s COVID-19 antiviral

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    Will COVID-19 help or hinder the quest to increase uptake of other vaccinations? ... Not just for the COVID-19 programmes, but for every other vaccine made these days.

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    The novel coronavirus (COVID-19) pandemic has created an unprecedented global health crisis and all industry sectors are working to assess both the impact and the optimal path forward. ... Clinical trials with the following characteristics are especially

  • COVID-19 hits supply chains COVID-19 hits supply chains

    Too much, way too much, cried our leaders, as the coronavirus (COVID-19) pandemic shuttered factories in the Hubei province. ... Reaction to the coronavirus crisis sheds light on fundamental shifts occurring in the US political landscape, according to

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....